November 24, 1999









Securities and Exchange Commission
450 5th. N.W.
Washington, D.C. 20549

Gentlemen:

This  letter  is to confirm that the reason I am  no  longer  the
auditor of record for Bio-Flourescent Technologies, Inc.  is  due
to  the  fact that I have redirected the focus of my professional
practice  and  as  such I no longer perform  audits  of  publicly
traded companies.

At  no  time  have I ever had a disagreement with Bio-Flourescent
Technologies, Inc. or its management and I have issued no adverse
opinions  about  the Company.  I agree with the  statements  made
regarding the change of accountants in Bio-Flourescent's Form 10-
SB, item 14, Changes in and Disagreements with Accountants.

Sincerely,

J. PAUL KENOTE, CPA, P.C.

/s/ J. Paul Kenote
J. Paul Kenote, CPA

     (b)  The following financial statements are filed as part of this
          report as pages b-1 through b-14 following the signature page:

          Report of Independent Certified Public Accountants

          Balance Sheets

          Statements of Operations

          Statements of Changes in Stockholders' Equity

          Statements of Cash Flows

          Notes to Financial Statements

Ranes International Holding, Inc.
(A Development Stage Company)

Condensed Balance Sheet
September 30, 1999
(Unaudited)

<TABLE>
                                        <C>
<S>

                ASSETS
CURRENT ASSETS:
Cash                                     30
Prepaid expenses                         110,250
Total assets                            110,280

 LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable - trade                 45,155
Accounts payable - related party         538,339
Note payable - related party             44,306
Note payable                             5,000
Total current liabilities               632,800
STOCKHOLDERS' EQUITY:
Common stock, $0.001 par value,          8,727
50,000,000 shares Authorized, 8,726,647
issued and outstanding
Additional paid-in Capital               4,440,905
Deficit accumulated during the           (4,972,152)
development stage
Total stockholders' equity              (522,520)
Total liabilities and stockholders'     110,280
equity
</TABLE>

The accompanying notes are an integral part of these condensed
financial statements.

Ranes International Holding, Inc.
(A Development Stage Company)
Condensed Statements of Operations For the Three and Nine Month
periods ended
September 30, 1999, 1998 and 1997 and
For the Period From Inception of Development Stage (February 15,
1990 to September 30, 1999)
(Unaudited)

<TABLE>

<S>                <C>               <C>               <C>

                   Three Month       Three Month       Three Month
                   period ended      period ended      period ended
                   Sept. 30, 1999    Sept. 30, 1998    Sept. 30, 1997
Net Sales
Selling, general   161,739           203,022           122,354
and administrative
expenses
Loss from          0161,739          -203,022          -122,354
operations
Interest income                      4,475             46
(net)
Loss before        -161,739          -198,547          -122,308
provision for
income taxes
Provision for
income taxes
Net loss           -161,739          -198,547          -122,308
Loss per common    $-0.02            $-0.02            $-21.66
share
Weighted average   8,726,647         8,378,821         5,646
number of common
shares outstanding
</TABLE>

The accompanying notes are an integral part of these condensed
financial statements.

Ranes International Holding, Inc.
(A Development Stage Company)
Condensed Statements of Operations For the Three and Nine Month
periods ended
September 30, 1999, 1998 and 1997 and
For the Period From Inception of Development Stage (February 15,
1990 to September 30, 1999) (Unaudited) (continued)

<TABLE>
                    <C>               <C>               <C>               <C>
<S>
                    Nine month        Nine month        Nine month        Cumulative From
                    period ended      period ended      period ended      the Inception of
                    Sept. 30, 1999    Sept. 30, 1998    Sept. 30, 1997    Development
                                                                          Stage (February
                                                                          15, 1990 to
                                                                          Sept. 30, 1999)
Net Sales                                               1,624     1,624
Selling, general    480,277           453,074           516,951           4,978,404
and administrative
expenses
Loss from           -480,277          -453,074          -515,327          -4,976,780
operations
Interest income                       4,475             46                4,628
(net)
Loss before         -480,277          -448,599          -515,281          -4,972,152
provision for
income taxes
Provision for
income taxes
Net loss            -480,277          -448,599          -515,281          -4,972,152
Loss per common     $-0.06            $-0.08            $-91,26
share
Weighted average    8,626,647         5,329,211         5,646
number of common
shares outstanding
</TABLE>

The accompanying notes are an integral part of these condensed
financial statements.

Ranes International Holding, Inc.
(A Development Stage Company)

Condensed Statements of Cash Flows
For the Three and Nine Month periods ended September 30, 1999,
1998 and 1999 and
For the Period From Inception of Development Stage (February 15,
1990 to September 30, 1999)
(Unaudited)
<TABLE>
<S>                           <C>               <C>               <C>
                              Three month       Three month       Three month
                              period ended      period ended      period ended
                              Sept. 30, 1999    Sept. 30, 1998    Sept. 30, 1997
Cash flows from operating
activities:
Net loss                      $-161,739         $-198,547         $-122,308
Adjustments to reconcile net
loss to net cash used in
operating activities
Provision for losses on
Media receivable
Write down to artwork
Amortization
Common stock issued for
services
Write off of labor contract
Deferred income taxes
Valuation allowance for
deferred income taxes
Change in assets and
liabilities:
Decrease/(increase) in trade                    43,316            6,196
account receivable
Decrease/(increase) in        65,125            37,500
prepaid expenses
Increase in checks issued in
excess of cash in bank
Increase/(decrease) in        95,850            18,020            116,097
accounts payable
Net cash used in operations   -764              -99,711           -15
Cash flows from financing
Proceeds from issuance of
note
Proceeds from issuance of                       100,000
common stock (net)
Net increase/(decrease) in    -764              289               -15
cash funds
Cash, beginning of period     794               0                 15
Cash, end of period           $30               $289              $0
</TABLE>

The accompanying notes are an integral part of these condensed
financial statements.

Ranes International Holding, Inc.
(A Development Stage Company)

Condensed Statements of Cash Flows
For the Three and Nine Month periods ended September 30, 1999,
1998 and 1999 and
For the Period From Inception of Development Stage (February 15,
1990 to September 30, 1999)
(Unaudited)
<TABLE>
<S>                       <C>               <C>               <C>               <C>
                          Three month       Three month       Three month       Cumulative From
                          period ended      period ended      period ended      the Inception of
                          Sept. 30, 1999    Sept. 30, 1998    Sept. 30, 1997    Development
                                                                                Stage (February
                                                                                15, 1990 to
                                                                                Sept. 30, 1999)
Cash flows from operating
activities:
Net loss                  $-480,277         $-448,599         $-515,281         $-4,972,152
Adjustments to reconcile
net loss to net cash used
in operating activities
Provision for losses on                                                         500,000
Media receivable
Write down to artwork                                                           400,000
Amortization                                                                    136,000
Common stock issued for   100,500           400,000                             1,878,855
services
Write off of labor                                                              55,000
contract
Deferred income taxes                                                           -1,526,000
Valuation allowance for                                                         1,526,000
deferred income taxes
Change in assets and
liabilities:
Decrease/(increase) in                      43,436            6,286
trade account receivable
Decrease/(increase) in    64,750            -212,500                            -110,250
prepaid expenses
Increase in checks issued                   -47
in excess of cash in bank
Increase/(decrease) in    270,462           112,999           377,668           583,494
accounts payable
Net cash used in          -44,565           -104,711          -131,327          -1,529,053
operations
Cash flows from financing 44,306            5,000                               49,306
Proceeds from issuance of                   100,000           125,000           1,479,777
note
Proceeds from issuance of                   100,000           125,000           1,479,777
common stock (net)
Net increase/(decrease)   -259              289               -6,327            30
in cash funds
Cash, beginning of period 289               0                 6,327             0
Cash, end of period       $30               $289              $0                $30
</TABLE>

The accompanying notes are an integral part of these condensed
financial statements.

Ranes International Holding, Inc.
(A Development Stage Company)

Notes to Condensed Financial Statements
September 30, 1999

1.   Operations and summary of significant accounting policies

     Operations:   Ranes   International  Holdings,   Inc.   (the
     "Company") was incorporated under the laws of the  state  of
     Nevada  on  February 15, 1990 as Partisan  Corporation.   On
     March  10,  1995,  the Company's name was  changed  to  Bio-
     Fluorescent  Technologies, Inc. then to Ranes  International
     Holdings, Inc. on March 10, 1998.

     Development  stage  enterprise:  The  Company  is  currently
     considered to be in the development stage and therefore  has
     adopted  the accounting and reporting standards of Financial
     Accounting Standards Board Statement No. 7, "Accounting  and
     Reporting by Development Stage Enterprises".

     The Company's initial business plan was based on developing,
     licensing  or otherwise acquiring state-of-the-art  advanced
     diagnostic  testing and screening technology  and  equipment
     capable  of early detection of human immune system disorders
     such as HIV-1, HIV-2 and Hepatitis B.  In February 1995, the
     Company  licensed  development stage  diagnostic  technology
     designed  to  detect AIDS, described as the  Mehica  GP  120
     system.

     In  July  1996,  the Company filed a complaint  against  the
     licenser  of  the technology.   Development activities  were
     suspended  and the Company wrote-off the un-amortized  costs
     of the Mehica GP 120 project as of July 1, 1996.

     In May 1996, the Company reorganized its management team and
     revised  its business development plan to focus on a "growth
     by  acquisition"  strategy.  The Company has  been  actively
     pursuing acquisition possibilities.

     Cash  and cash equivalents: The company considers all highly
     liquid  investments with a maturity of three months or  less
     at   the   date  of  acquisition  to  be  cash  equivalents.
     Supplemental  disclosure of non-cash  transactions  were  as
     follows for the three month period ended March 31, 1999:

      Issuance of common stock in exchange
       for services                              $100,500

     Income  taxes: Income taxes are accounted for  and  reported
     using an asset and liability approach.  Deferred income  tax
     assets and liabilities are computed annually for differences
     between the financial statement and tax basis of assets  and
     liabilities  that  will  result  in  taxable  or  deductible
     amounts  in the future based on enacted tax laws  and  rates
     applicable  to  the  periods in which  the  differences  are
     expected to effect taxable income.

    Operations and summary of significant accounting policies
                           (continued)

     Valuation  allowances  are  established  when  necessary  to
     reduce  deferred  tax assets to the amount  expected  to  be
     realized.   Income  tax  expense  is  the  tax  payable   or
     refundable  for the period plus or minus the  change  during
     the year in deferred tax assets and liabilities.

     Deferred tax assets result from net operating losses not yet
     utilized  for tax purposes.  Valuation allowances have  been
     provided  for those deferred tax assets as their utilization
     are uncertain.

     Reporting  Comprehensive Income: In June 1997, Statement  of
     Financial Accounting Standards ("SFAS") No. 130, " Reporting
     Comprehensive   Income"   was  issued,   which   established
     standards for reporting and display of comprehensive  income
     and  its  components as separate amounts  in  the  financial
     statements.   Comprehensive income includes all  changes  in
     equity  during a period of an enterprise that  results  from
     recognized transactions and other economic events other than
     transactions with owners.  This statement requires all items
     that  are  to  be recognized under accounting  standards  as
     components  of  comprehensive  income  be  reported   in   a
     financial  statement  that  is  displayed  with   the   same
     prominence  as  other financial statements.  This  statement
     affects  only  financial  statement  presentation.   As   of
     December  31,  1998, the Company does not  carry  any  items
     required  to be disclosed as other comprehensive  income  in
     accordance with the statement.

     Net loss per common share: Net loss per share is computed by
     dividing  net loss by the weighted average number of  common
     shares outstanding during the periods.  The weighted average
     number of common stock shares outstanding was 7,865,052  for
     the  year ended December 31, 1998; 58,676 for the year ended
     December  31,  1997; and 860,278 for the  cumulative  period
     from  February  15,  1990 (inception) through  December  31,
     1998.

     Significant   risks  and  uncertainties:  The   process   of
     preparing  financial statements in conformity with generally
     accepted accounting principles requires the use of estimates
     and   assumptions   regarding  certain  types   of   assets,
     liabilities,  revenues  and  expenses.  Management  of   the
     Company has made certain estimates and assumptions regarding
     the  realization of receivables and the utilization  of  net
     operating  losses for income tax purposes.   Such  estimates
     and  assumptions primarily relate to unsettled  transactions
     and  events  as  of  the  date of the financial  statements.
     Accordingly, upon settlement, actual results may differ from
     estimated amounts.

     Recently Issued Accounting Pronouncements:

     Accounting   for   Derivative   Instruments   and    Hedging
     Activities:  In  June 1998, SFAS No. 133, "  Accounting  for
     Derivative  Instruments and Hedging Activities" was  issued.
     The  Statement requires that all derivatives be  carried  on
     the  balance  sheet at fair value and changes  in  the  fair
     value  of  derivatives be recognized  in  income  when  they
     occur,   unless  the  derivatives  qualify  as   hedges   in
     accordance with the standard.  If a derivative qualifies  as
     a  hedge, a company can elect to use hedge accounting.   The
     type of accounting to be applied varies

    Operations and summary of significant accounting policies
                           (continued)

     Recently Issued Accounting Pronouncements (continued):

     depending  on  the  nature of the  exposure  that  is  being
     hedged,  and the standard defines three hedge risks:  change
     in  fair  value, change in cash flows and change in  foreign
     currency.

     A  fair-value hedge represents the hedge of an  exposure  to
     changes  in  the  fair value of an asset,  liability  or  an
     unrecognized firm commitment.  Changes in fair value  hedges
     are  recognized in earnings, as well as the gain or loss  on
     the  hedged  item attributable to the hedged risk.   Certain
     criteria must be met in order for a hedging relationship  to
     qualify as a fair-value hedge.

     A  cash-flow  hedge is a hedge of an exposure to variability
     in  cash  flows  that is attributable to a particular  risk.
     That  exposure may be associated with an existing recognized
     asset  or  liability  or  a  forecasted  transaction.    The
     effective portion of a hedging instrument's gain or loss  is
     initially  reported  as a component of  other  comprehensive
     income and is reclassified as a component of earnings in the
     same  period  or  periods during which the hedge  forecasted
     transaction  affects  earnings.  As in  fair  value  hedges,
     certain  criteria  must  be  met  in  order  for  a  hedging
     relationship  to  qualify  as a  cash-flow  hedge.  foreign-
     currency  hedge  can be a fair-value hedge  or  a  cash-flow
     hedge of the foreign currency exposure, therefore it follows
     the  same  principles as those that apply to the  accounting
     for non-foreign hedges with some particularities defined  in
     the statement.

     This statement is effective for fiscal years beginning after
     June   15,   1999   and  cannot  be  applied  retroactively.
     Management believes that the adoption of this statement will
     not  have  a  material  effect on  the  Company's  financial
     position or results of operations.

     Accounting  for the Cost of Computer Software Developed  for
     Internal  Use:  In  March 1998, the  American  Institute  of
     Certified Public Accountants issued Statement of Position 98-
     1,  " Accounting for the Cost of Computer Software Developed
     for  Internal Use" ("SOP 98-1"), which will become effective
     for  financial statements for the year beginning January  1,
     1999, with early adoption encouraged.  SOP 98-1 requires the
     capitalization  of  eligible costs of  specified  activities
     related  to  computer  software developed  or  obtained  for
     internal  use.   Management does not believe the  impact  of
     adoption  will  have  a  material effect  on  the  Company's
     financial position or results of operations.

     Reclassifications:  Certain amounts in  the  1997  financial
     statements  have been reclassified to conform  to  the  1998
     presentation.

2.   Continued operations

     The   Company  has  incurred  net  operating  losses   since
     inception,   and   through  December   31,   1998   business
     development  costs  have  totaled approximately  $4,500,000.
     These  expenditures  have  been funded  primarily  with  the
     proceeds from the private sales of equity securities as well
     as  with  the  issuance  of common  stock  in  exchange  for
     services  and  indebtedness.   Since  inception,  management
     activities  have  been  devoted  substantially  to   raising
     capital,  identifying business opportunities,  or  acquiring
     assets  in order to generate revenues.  These factors  raise
     substantial doubt about the Company's ability to continue as
     a going concern.

     The   Company   continues  to  actively  pursue  acquisition
     possibilities.

     The  accompanying  financial statements have  been  prepared
     assuming  that the Company will continue as a going concern.
     The  financial  statements do not  include  any  adjustments
     relating to the recoverability and classification of  assets
     or  the amount and classification of liabilities that  might
     result  should the Company be unable to continue as a  going
     concern.

3.   Reverse common stock spit

     Effective January 17, 1998, the Board of Directors  approved
     a  one share for 100 shares reverse stock split.  All common
     stock shares, weighted average shares, and per share amounts
     have  been restated in the accompanying financial statements
     to reflect the reverse stock split.

4.   Media products and services receivable

     In  October  1995, the Company issued 2,000  shares  of  its
     common  stock in exchange for script writing, music scoring,
     radio commercial production and radio advertising time to be
     received  in  the  future valued at approximately  $500,000.
     During  1998, the Company provided an allowance of  $500,000
     against this asset.

5.   Stock compensation plans

     On   August   29,  1996,  the  Company  adopted  fixed   and
     performance  based  stock compensation plans.   The  Company
     accounts for the fair value of its grants under those  plans
     in   accordance  with  Statement  of  Financial   Accounting
     Standards    No.   123,   "Accounting   for   Stock    Based
     Compensation".   The  compensation  cost  that  was  charged
     against  income  for these plans was $50,000  for  the  year
     ended December 31, 1997.

     Fixed  stock  option  plan: Under the 1996  Incentive  Stock
     Option Plan, the Company may grant options to its employees,
     directors,  consultants and advisors for up to 8,667  shares
     of  its  $0.001 par value common stock.  The exercise  price
     for stock granted pursuant to a tax-qualified option plan is
     to  be  greater  than or equal to the market  price  of  the
     Company's stock on the date of grant.  The exercise price of
     stock granted pursuant to a non-qualified stock option  plan
     is to be greater than or equal to 85% of the market price of
     the Company's common

Business   and   summary  of  significant   accounting   policies
(continued)

Stock  compensation plans (continued) stock on the date of grant.
The maximum term for an option is ten years.  Options are granted
at  the  discretion of the Board of Directors.  No  options  were
granted during the year ended December 31, 1998 or 1997.

Performance  based  stock plan: The Company  may  grant  selected
executives and other key individuals deferred stock awards  whose
vesting  is  contingent upon the future performance  of  services
under  terms and conditions specified by the Board of  Directors.
The  number  of shares subject to grant under this plan  together
with the number of shares subject to option under the fixed stock
option plan cannot exceed 8,667.

A summary of the status of the Company's stock option plans as of
December  31,  1998 and 1997 and changes during  the  years  then
ended are presented below:

 <TABLE>
                           <C>               <C>
 <S>
                           Shares            Weighted average
                                             exercise price
 Outstanding at January    6,634             $165
 1, 1997
 Granted
 Exercised
 Forfeited                 (167)             $450
 Expired
                           6,467             $156
 Outstanding at December
 31, 1997
 Granted
 Exercised
 Forfeited
 Expired                   (1,967)           $(159)
                           4,500             $154
 Outstanding at December
 31, 1998

 </TABLE>

The  following  table summarized information about stock  options
outstanding at December 31, 1998:
 <TABLE>
 <S>     <C>               <C>               <C>        <C>               <C>
 Option  Exercise price    Options           Weighted   Options           Aggregate
 grant                     outstanding       average    exercisable       proceeds
 date                      12/31/98          remaining  12/31/98          12/31/98
                                             contractu
                                             al life
 8/29/9  $134              3,000               2.67     3,000             $
    6                                          years                      4
                                                                          0
                                                                          2
                                                                          ,
                                                                          0
                                                                          0
                                                                          0
 8/29/9  $180              1,333               2.67     1,333             $239,940
    6                                          years
 8/29/9  $375              167                 32.33    167               51,375
    6                                          years
                           4,500                        4,500             $693,315
 </TABLE>

6.   Income taxes

The benefit for income taxes consisted of the following:
 <TABLE>
 <S>                   <C>               <C>               <C>
                       Year ended 1998   December 31,      Cumulative
                                         1997              activity during
                                                           development
                                                           stage February
                                                           15, 1990
                                                           (inception)
                                                           through December
                                                           31, 1998
 Federal:
Currently payable
Deferred               (195,699)         (260,641)         (1,526,000)
                       (195,699)         (260,641)         (1,526,000)
Change in valuation    195,699           260,641           (1,526,000)
 allowance
Benefit for income
 taxes
</TABLE>

Deferred income taxes consisted of the following at December 31:

 <TABLE>
                                     <C>               <C>
 <S>
                                     1998              1997

 Deferred tax assets - net           1,526,000         1,330,30
 operating loss carryovers                             1
 Valuation allowance                 (1,526,000)
 </TABLE>

     The  Company  has  a  net operating  loss  carryover  as  of
     December  31, 1998 of approximately $1,526,000 available  to
     offset  future  taxable income, if any.   In  the  event  of
     ownership  changes aggregating 50% or more in any three-year
     period,  the amount of loss carryovers that become available
     for utilization in any year may be limited.  If not utilized
     against  future  taxable  income,  the  net  operating  loss
     carryovers will expire between the years 2005 and 2013.

7.   Legal proceedings

     The  Company  had  secured worldwide rights to  manufacture,
     market  and  sell  the  Mehica GP 120 ("Mehica")  System  in
     February  1995.   On  July 19, 1996,  the  Company  filed  a
     complaint  in  the  United States  District  Court  for  the
     District  of  Maryland  against the  licenser,  and  others,
     seeking  declaratory  relief, damages and  other  relief  in
     respect  to certain agreements relating to the rights  to  a
     proprietary automated system for detection of the HIV  virus
     and  for  use in mass screening of individuals, the Packaged
     Antigen Kit and the Mehica.

     On  July  30, 1996, the defendants filed an answer, counter-
     claim, and third party complaint, seeking declaratory relief
     with  respect  of the agreements and damages.  A  settlement
     order  issued by the court to dismiss the case  was  entered
     into  on  September 25, 1997.  Both parties elected  to  not
     reopen  the case within the allowable 30 days following  the
     order and the case was dismissed.

8.   Contingency

     The  State  of  Nevada's  Revised  Statue  provides  that  a
     corporation  that has been reinstated to a  status  of  good
     standing continues to be liable for past acts and errors and
     omissions, whether engaged in directly or through its former
     officers and directors.  Management of the Company does  not
     believe  any  past acts, errors and omissions or  unasserted
     claims' and assessments exist or have occurred, however they
     are  continently liable for such matters.  No provisions for
     losses,  if  any,  have been provided  in  the  accompanying
     finical  statements  because  of  the  uncertainty  of  such
     matters.

9.   Related party transactions

     On  August  31, 1998, the Company entered into a  three-year
     agreement with a company owned by an Officer of the  Company
     for  public  relation  services.  Under  the  terms  of  the
     agreement,  the  Company is obligated  to  pay  this  public
     relations  company  $15,000 per month,  plus  certain  other
     costs.  The agreement contains renewal provisions.

This same Officer provides management services and office support
services to the Company.  Such services include office personnel,
supplies and the maintenance of the Company's principal executive
office  in Scottsdale, Arizona.  During 1998, the Company  issued
5,000,000  shares of their common stock in exchange for  $100,000
of  indebtedness it owed this Officer for management  and  office
support   services.    The  Company  also   paid   this   Officer
approximately $94,600 during 1998 ($637,500 during 1997).  As  of
December  31,  1998,  the  Company  owed  this  Officer  $256,439
($40,919  at  December  31,  1997),  which  is  included  in  the
accompanying  balance  sheets  as  payable  to  related  parties.
During  the  nine  month  period ended September  30,  1999,  The
Company incurred an additional $288,90000 in consulting fees  and
in  addition a note of $44,306 for cash advances to the  Company.
The  net accrued liability to the related company in addition  to
the Cash Note amounted to $538,339 at September 30, 1999.

                           SIGNATURES

In accordance with Section 13 or 15(d) of the Securities Exchange
Act, the Registrant caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.

Date:  November 3, 1999  RANES INTERNATIONAL HOLDING, INC.
                                    (Registrant)

                         By:  /s/  Jan J. Olivier
                            Jan J. Olivier, President/Director

                         By:  /s/  Wynn J. Bott
                            Wynn J. Bott, Controller